Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

By F. Davies, N. Raje, T. Hideshima, S. Lentzsch, G. Young, Y. Tai, B. Lin, K. Podar, Deepak K. Gupta, D. Chauhan and 7 more. Blood, 2001

935 citations recorded by the source corpus.

Subfields: Hematology, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/72177532fb97d38579130bcd578797813204678b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Bartlett
2. K. Dredge
3. A. Dalgleish

Citations in the corpus

• The evolution of thalidomide and its IMiD derivatives as anticancer agents (2004, background): “For example, CC-5013 seems to augment the cytotoxicity of natural-killer cells, leading directly to lysis of MM cell”